ESR Rev5
ESR Rev5
Classified Document:
Code:
This document is distributed only to limited number of DOH and selected NGO staff in order to improve common awareness on reports and rumours of
events which may have national/ international implications. Please send new or additional information on this or other public health events.
✘ Yes
DOH-EB-AEHMD-QMOP-03-Form2 Rev.5
to index: Daughter, Contact #
0927-700-6700,Civil Status:
Married, Occupation: Brgy.
Chairman, Present
Address:#230 Perez, Bulakan,
Bulacan.Home address same as
present, Date of exposure to
index:4/20/2023,
Asymptomatic, Date of First
Swab:4/20/2023,DRU: RHU
Bulakan, RT-PCR Result:
4/21/2023 Negative,
Vaccinated with Astrazeneca
1st Dose:3/29/2021
2nd Dose:06/09/2021
!st Booster Dose:12/14/2021
Pfizer.
4. Arguson,Maja Isabel
Meneses,14 y/o, Date of Birth:
03/29/2009, Female,
Relationship to index: Friends,
Contact # 0917-804
3584,Single, Student at ICSL-
Malolos, Present address: #
3406 Purok 3, Bambang
Bulakan, Bulacan, date of
exposure to index:
04/18/2023, Asymptomatic,
Vaccinated with Pfizer, 1st
Dose: 11/12/2021; 2nd Dose:
DOH-EB-AEHMD-QMOP-03-Form2 Rev.5
12/03/2021, DRU; RHU
Bulakan. Vaccinated with 1st
Booster Dose:11/04/2022.
Patient’s Contact #:
0945-889-5387
DOH-EB-AEHMD-QMOP-03-Form2 Rev.5
Result: POSITIVE, Date:
12 IHR Notification decision questions Is the public health impact serious? ✘ No
Yes
Is the event unusual or unexpected?
Yes ✘ No
Is there a significant risk of international spread?
Is there a significant risk of international travel or Yes ✘ No
trade restriction? Yes ✘ No
DISCLAIMER: Every effort has been made to provide accurate, up-to-date information. However, the knowledge base is dynamic and errors can occur. By using the information
contained in this list, the reader assumes all risks in connection with such use. The EB shall not be held responsible for errors, omissions nor liable for any special,
consequential or exemplary damages resulting, in whole or in part, from any reader's use or reliance upon this material.
DOH-EB-AEHMD-QMOP-03-Form2 Rev.5